Cargando…
Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
Management of high-grade gliomas remains a complex challenge. Standard of care consists of microsurgical resection, chemotherapy and radiation, but despite these aggressive multimodality therapies the overall prognosis remains poor. A major focus of ongoing translational research studies is to devel...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880302/ https://www.ncbi.nlm.nih.gov/pubmed/31747788 http://dx.doi.org/10.2217/cns-2019-0001 |